52 results
424B4
PCSA
Processa Pharmaceuticals Inc
29 Jan 24
Prospectus supplement with pricing info
4:15pm
by including the pre-clinical and clinical studies to justify the benefit-risk assessment required for FDA approval when designing the development programs
8-K
EX-10.1
lyzdkb1w
24 Mar 22
Entry into a Material Definitive Agreement
4:30pm
424B5
op6mrzvb
20 Aug 21
Prospectus supplement for primary offering
4:46pm
8-K
EX-1.1
i7epy6d hm9nl20
20 Aug 21
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.2
m9kf90
18 Feb 21
Processa Pharmaceuticals Announces $10.2 Million Strategic Financing
10:08am
424B4
boa3s6jh tgkr
5 Oct 20
Prospectus supplement with pricing info
4:16pm